The topical pain relief market is expected to experience growth, with a reported compound annual growth rate of 5.2%. Related markets, including compounding pharmacy and transdermal drug delivery systems, are also anticipated to grow, with some reports suggesting the compounding pharmacy market could be worth between $31.77 billion and $33.63 billion by the mid-2030s. The growth of these markets may be driven by factors such as demand for personalized medicine and advancements in pain relief technologies.